Stay updated with breaking news from Nasdaq Neph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nephros, Inc. (NASDAQ:NEPH – Get Rating)’s stock price dropped 0.5% during trading on Thursday . The company traded as low as $0.99 and last traded at $1.01. Approximately 1,377 shares traded hands during trading, a decline of 93% from the average daily volume of 18,729 shares. The stock had previously closed at $1.01. Nephros Stock […]
Nephros, Inc. (NASDAQ:NEPH – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 51,000 shares, an increase of 82.1% from the May 15th total of 28,000 shares. Currently, 0.6% of the company’s shares are sold short. Based on […]
A number of research firms have changed their ratings and price targets for Nephros (NASDAQ: NEPH): 4/20/2022 – Nephros was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “buy” rating. They now have a $5.25 price target on the stock. According to Zacks, “Nephros develops advanced End Stage Renal Disease, […]
Nephros (NASDAQ:NEPH – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the […]
Nephros (NASDAQ:NEPH – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs […]